The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Phenomic AI has recently announced a strategic collaboration and licensing agreement with Boehringer Ingelheim focusing on the identification of targets crucial in stromarich cancers The collaboration
OncoResponse a clinicalstage biotech company specializing in immunotherapies derived from the immune systems of Elite Cancer Responders has recently initiated the Phase trial for OR
Ethris GmbH a leading biotechnology company focused on advancing nextgeneration RNA therapeutics and vaccines has secured approval from the United Kingdom Medicines and Healthcare products
RoslinCT a Contract Development and Manufacturing Organization specializing in cell and gene therapy has announced its involvement in manufacturing the worlds first CRISPRbased therapy
TC BioPharm PLC a biotechnology company focused on developing allogeneic gammadelta T cell therapies for cancer has received clearance from the FDA
Today the US Food and Drug Administration has granted approval for Ogsiveo nirogacestat tablets marking a significant milestone as the first drug sanctioned for the treatment
Priothera Ltd has announced that the US Food and Drug Administration granted Orphan Drug designation to its compound mocravimod a SP receptor modulator This designation is for the treatment aimed
Medivir AB recently reported the successful completion of the development of an updated formulation of fostrox intended for commercial manufacturing Fostrox created by the pharmaceutical company
ErKim Pharmaceuticals an international pharmaceutical company specializing in the commercialization of novel therapies has joined the effort to combat antimicrobial resistance by participating in World AMR
Boehringer Ingelheim has recently completed the acquisition of T Pharmaceuticals AG a Swiss biotech company for an amount of up to million CHF T Pharma specializes in a unique therapy platform
